Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 4/20 | 0.53 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.46 |
| ▸ | HSP90AB1 | P08238 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.41 |
| ▸ | AHR | P35869 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1104981 | 0.80 | IDO1 (0.50) | HSD11B1KCNH2NPC1RAB9AMAPT | |
| SCHEMBL3759812 | 0.80 | LMNA (0.45) | HSD11B1HSP90AA1HSP90AB1LMNAMAPT | |
| SCHEMBL366947 | 0.79 | IDO1 (0.50) | NPC1RAB9ALMNAMAPTSMN1; SMN2 | |
| SCHEMBL14399711 | 0.79 | IDO1 (0.49) | KCNH2NPC1RAB9AMAPTSMN1; SMN2 | |
| SCHEMBL9383732 | 0.77 | KMT2A (0.53) | HSD11B1NPC1RAB9AHSP90AA1HSP90AB1 | |
| SCHEMBL18713550 | 0.76 | KMT2A (0.37) | HSD11B1KCNH2NPC1RAB9AHSP90AA1 | |
| SCHEMBL14371220 | 0.76 | NPC1 (0.45) | KCNH2NPC1RAB9ALMNAMAPT | |
| SCHEMBL14996550 | 0.75 | HSD11B1 (0.54) | HSD11B1KCNH2NPC1HSP90AA1HSP90AB1 | |
| SCHEMBL25263600 | 0.75 | SCN9A (0.48) | NPC1RAB9ALMNAMAPTSMN1; SMN2 | |
| SCHEMBL2751070 | 0.74 | HSD11B1 (0.49) | HSD11B1NPC1HSP90AA1HSP90AB1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160122327-A1 | STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI | BASF SE (DE) | 2016-05-05 | — | — | US | disclosed |
| US-8426631-B2 | Fungicidal compounds, method for the production thereof, and use thereof to combat damaging fungi, and agents comprising the same | BASF SE (DE) | 2013-04-23 | — | — | US | disclosed |
| US-20100304966-A1 | Fungicidal Compounds, Method For the Production Thereof, And Use Thereof To Combat Damaging Fungi, And Agents Comprising The Same | BASF SE (DE) | 2010-12-02 | — | — | US | disclosed |
| US-20100016313-A1 | INTESTINAL ALKALINE PHOSPHATASE MODULATORS AND USES THEREOF | BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) | 2010-01-21 | — | — | US | disclosed |
| US-6365552-B1 | AS HERBICIDE | BASF AKTIENGESELLSCHAFT (DE) | 2002-04-02 | — | — | US | disclosed |
| EP-0759907-B1 | SUBSTITUTED 3-PHENYLPYRAZOLES FOR USE AS HERBICIDES | BASF AG (DE) | 2001-10-10 | — | — | EP | disclosed |
| US-5928999-A | HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1999-07-27 | — | — | US | disclosed |
| US-5744426-A | HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1998-04-28 | — | — | US | disclosed |
| CN-1152305-A | Substituted 3-phenylpyrazoles as herbicides | BASF AG (DE) | 1997-06-18 | — | — | CN | disclosed |
| EP-0759907-A1 | SUBSTITUTED 3-PHENYLPYRAZOLES FOR USE AS HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1997-03-05 | — | — | EP | disclosed |
| WO-1995033728-A1 | SUBSTITUTED 3-PHENYLPYRAZOLES AS HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1995-12-14 | — | — | WO | disclosed |
| WO-1995032188-A1 | SUBSTITUTED 3-PHENYLPYRAZOLES FOR USE AS HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1995-11-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160122327-A1 | STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI | SNX1, DPM1, SNU13 | HSD11B1 2575/4885KCNH2 3747/4885NPC1 634/4885 |
| US-20100016313-A1 | INTESTINAL ALKALINE PHOSPHATASE MODULATORS AND USES THEREOF | ALPI, SI, FABP2 | HSD11B1 2168/4885KCNH2 4297/4885NPC1 1539/4885 |
| US-20100304966-A1 | Fungicidal Compounds, Method For the Production Thereof, And Use Thereof To Combat Damaging Fungi, And Agents Comprising The Same | CYP51A1, ERG28, CAT | HSD11B1 244/4885KCNH2 2840/4885NPC1 1402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.